Bibliothèque de L'IMIST/CNRST

Now, with the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence-based practice is a more important force in health care delivery than ever. This new third edition, written by the world's leading cardiologists, provides graded evidence-based reviews of the major trials together with recommendations for optimum management, and now includes new grading and recommendation methodology. This is a unique book in the field of cardiology, and the largest evidence based clinical cardiology text.

Includes bibliographical references and index.

Evidence-based decision making: patient-physician interface -- Obtaining incremental information from diagnostic tests -- Clinical trials and meta-analysis -- Understanding concepts related to health economics -- Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention -- Implementing evidence-based medicine in cardiology -- The application of evidence-based medicine to employment fitness standards: the transportation industries with special reference to aviation -- Global perspective on cardiovascular disease -- Avoidance of worldwide vascular deaths and total deaths from smoking -- Tobacco and cardiovascular disease: achieving smoking cessation in cardiac patients -- Lipids and cardiovascular disease -- Use of lipid-lowering agents in the prevention of cardiovascular disease -- Blood pressure and cardiovascular disease -- Dysglycemia and the risk of cardiovascular events -- Physical activity and exercise in cardiovascular disease prevention and rehabilitation -- Psychosocial factors -- The social determinants of cardiovascular disease -- Obesity -- Ethnicity and cardiovascular disease -- Fetal origins of coronary artery disease -- Genetics of coronary heart disease -- Molecular genetics of cardiovascular disorders -- Diet and cardiovascular disease -- Integrating approaches to prevention of cardiovascular disease -- Medical management of stable coronary artery disease -- Percutaneous intervention -- Surgical coronary artery revascularization -- Comparisons of percutaneous coronary intervention and coronary artery bypass grafting -- Non-ST segment elevation acute coronary syndromes: unstable angina and non-ST segment elevation myocardial infarction -- Early prehospital management of ST segment elevation myocardial infarction -- Reperfusion therapies for ST segment elevation myocardial infarction -- Antithrombotic therapeis for patients with ST segment elevation myocardial infarction -- Complications after myocradial infarction -- An integrated approach to the management of patients after the early phase of ST segment elevation myocardial infarction -- Atrial fibrillation: rhythm and rate control therapies -- Atrial fibrillation: upstream therapies -- Atrial fibrillation: antithrombotic therapy -- Ablation therapy for atrial fibrillation -- Supraventricular tachycardia -- Prevention and treatment of life-threatening ventricular arrhythmia and sudden death --

Pacemaker therapy, including cardiac resynchronization therapy -- Syncope -- Cardiopulmonary resuscitation -- Arrhythmias due to monogenic disorders -- Arrhythmiagenic right ventricular cardiomyopathy -- Epidemiology and prevention of heart failure and management of asymptomatic left ventricular systolic dysfunction -- Management of overt heart failure -- Acute myocarditis and dilated cardiomyopathy -- Management of hypertrophic cardiomyopathy -- Infective and infiltrative cardiomyopathies -- Chagas' heart disease -- Pericardial disease: an evidence-based approach to clinical management -- Rheumatic heart disease: prevention and acute treatment -- Mitral valve disease: indications for surgery -- Surgical indications in aortic valve disease -- Non-surgical indications in aortic valve therapy: balloon valvuloplasty and transcatheter aortic valve replacement -- Balloon valvuloplasty: mitral valve -- Valve repair and choice of valve -- Infective endocarditis -- Antithrombotic therapy after heart valve replacement -- Stroke -- Heart disease and pregnancy -- Adult congenital heart disease -- Venous thromboembolic disease -- Peripheral arterial disease -- Cardiac risk in those undergoing non-cardiac surgery -- Clinical management of diseases of the aorta -- Cardiac transplantation: indications and postoperative management -- Renal dysfunction -- Pulmonary hypertension -- Clinical applications of external evidence -- Stable angina: choice of PCI versus CABG versus drugs -- Non-ST segment acute coronary syndrome -- Acute ST segment elevation myocardial infarction -- Secondary prevention strategies post myocardial infarction -- Heart failure -- Atrial fibrillation -- The case for and against implantable cardioverter defibrillators in patients with coronary artery disease -- Bradyarrhythmias - choice of pacemakers -- Peripheral arterial disease with suspect coronary artery disease -- Valvular heart disease: timing of surgery.